Patent · US Active

Apelin receptor agonists and methods of use thereof

US12071414B2 · kind B2 · utility

0Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2023
Grant dateAug 27, 2024
Priority date
Expiry dateApr 28, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.